Reprogramming Strategies of Promoting Optic Nerve Regeneration and Vision Restoration
Reprogramming Strategies of Promoting Optic Nerve Regeneration and Vision Restoration
批准号:
9322464
负责人:
ZHIGANG HE
金额:
$44.25万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-08-01 至 2021-07-31
关键词:
AdultAnatomyAxonBiological AssayBlindnessBrainCandidate Disease GeneCellsCircadian RhythmsDevelopmentExhibitsEyeFRAP1 geneGenetic TranscriptionGrowthIGF1 geneLabelLightMethodsModelingMolecularMusNatural regenerationOptic NerveOptic Nerve InjuriesPTEN genePathway interactionsPhotosensitivityPilot ProjectsProteinsRecovery of FunctionResearchRetinal Ganglion CellsSOX11 geneSOX4 geneStem Cell ResearchTechnologyVisionVisual Pathwaysaxon regenerationbasebehavior testcircadian pacemakercombinatorialexperimental studyfunctional outcomesfunctional restorationimprovedinduced pluripotent stem cellinjuredinsightmelanopsinnerve supplyneuronal survivalnovelnovel strategiesoptic nerve regenerationosteopontinoverexpressionpreventregenerativerestorationretinal progenitor cellsuprachiasmatic nucleustranscription factorvisual information
中文摘要
项目总结
英文摘要
Project Summary
The damage of optic nerve axons prevents the relay of the visual information from the eye to the brain, leading
to the loss of vision. Therefore, our research has been focusing on developing methods to promote efficient
optic nerve axon regeneration and to re-build functional visual pathways. Recent studies have led to the
developments of several novel strategies that stimulate axon regeneration, however each of these methods
only achieved regeneration in subsets of retinal ganglion cells (RGCs). Thus, to restore vision, new strategies
are pressingly needed to promote regeneration of multiple types of RGCs. Inspired by the transcriptional
reprogramming technology for obtaining iPS cells, we hypothesized that over-expressing certain transcription
factors in adult RGCs could reprogram them into a young-RGC-like growth competent state. To this end, we
have performed a screen for a list of transcription factors that are normally expressed during the differentiation
stage of retinal progenitor cells, to examine which one(s), when overexpressed in adult RGCs, could enable
significant axon regeneration using an intraorbital optic nerve injury model. Interestingly, we found that forced
expression of the transcription factor Sox11, and to a less extent Sox4, resulted in marked optic nerve
regeneration. Preliminary analysis revealed that the effects of Sox11 are likely different from those triggered by
PTEN deletion (see Approach). Furthermore, while PTEN deletion promotes the regeneration selectively from
alpha type of RGCs, Sox11 overexpression promotes the regeneration of melanopsin-expressing intrinsically
photosensitive RGCs (ipRGCs) and other un-determined types of RGCs. These initial findings suggested a
novel rationale for promoting optic nerve regeneration by reinstitute Sox11 expression. Here, we propose to
explore the underlying mechanisms by which Sox11 stimulates RGC axon regeneration and its potential
application, either by itself or in combination with others, in achieving functional recovery.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanism and Optimization of CBD-mediated analgesic effects
-
批准号:10288673
-
项目类别:
-
资助金额:$13.22万
-
财政年份:2019
-
负责人:ZHIGANG HE
-
依托单位:
KCC2 and spinal cord injury
-
批准号:9884826
-
项目类别:
-
资助金额:$43.06万
-
财政年份:2019
-
负责人:ZHIGANG HE
-
依托单位:
KCC2 and Spinal Cord Injury
-
批准号:10599160
-
项目类别:
-
资助金额:$42.02万
-
财政年份:2019
-
负责人:ZHIGANG HE
-
依托单位:
Mechanism and Optimization of CBD-mediated analgesic effects
-
批准号:10662464
-
项目类别:
-
资助金额:$67.09万
-
财政年份:2019
-
负责人:ZHIGANG HE
-
依托单位:
Mechanism and Optimization of CBD-mediated analgesic effects
-
批准号:10018669
-
项目类别:
-
资助金额:$67.09万
-
财政年份:2019
-
负责人:ZHIGANG HE
-
依托单位:
Mechanism and Optimization of CBD-mediated analgesic effects
-
批准号:10227071
-
项目类别:
-
资助金额:$67.09万
-
财政年份:2019
-
负责人:ZHIGANG HE
-
依托单位:
CRSIPR screening for novel regulators of retinal ganglion cell survival and axonal regeneration
-
批准号:9920148
-
项目类别:
-
资助金额:$53.37万
-
财政年份:2019
-
负责人:ZHIGANG HE
-
依托单位:
Mechanism and optimization of CBD-mediated analgesic effects (Diversity Supplement)
-
批准号:10915759
-
项目类别:
-
资助金额:$5.02万
-
财政年份:2019
-
负责人:ZHIGANG HE
-
依托单位:
Mechanism and optimization of CBD-mediated analgesic effects (Diversity Supplement)
-
批准号:10714331
-
项目类别:
-
资助金额:$2.82万
-
财政年份:2019
-
负责人:ZHIGANG HE
-
依托单位:
KCC2 and Spinal Cord Injury
-
批准号:10094088
-
项目类别:
-
资助金额:$42.02万
-
财政年份:2019
-
负责人:ZHIGANG HE
-
依托单位:
CRSIPR screening for novel regulators of retinal ganglion cell survival and axonal regeneration
-
批准号:10402334
-
项目类别:
-
资助金额:$51.77万
-
财政年份:2019
-
负责人:ZHIGANG HE
-
依托单位:
Mechanism and optimization of CBD-mediated analgesic effects (Admin Supplement)
-
批准号:10847933
-
项目类别:
-
资助金额:$33.99万
-
财政年份:2019
-
负责人:ZHIGANG HE
-
依托单位:
CRSIPR screening for novel regulators of retinal ganglion cell survival and axonal regeneration
-
批准号:10610910
-
项目类别:
-
资助金额:$53.37万
-
财政年份:2019
-
负责人:ZHIGANG HE
-
依托单位:
Mechanism and optimization of CBD-mediated analgesic effects (Admin Supplement)
-
批准号:10712799
-
项目类别:
-
资助金额:$7.47万
-
财政年份:2019
-
负责人:ZHIGANG HE
-
依托单位:
Mechanism and Optimization of CBD-mediated analgesic effects
-
批准号:9895134
-
项目类别:
-
资助金额:$69.01万
-
财政年份:2019
-
负责人:ZHIGANG HE
-
依托单位:
KCC2 and Spinal Cord Injury
-
批准号:10352309
-
项目类别:
-
资助金额:$42.02万
-
财政年份:2019
-
负责人:ZHIGANG HE
-
依托单位:
Mechanism and Optimization of CBD-mediated analgesic effects
-
批准号:10468403
-
项目类别:
-
资助金额:$26.43万
-
财政年份:2019
-
负责人:ZHIGANG HE
-
依托单位:
Mechanism and Optimization of CBD-mediated analgesic effects
-
批准号:10475030
-
项目类别:
-
资助金额:$67.09万
-
财政年份:2019
-
负责人:ZHIGANG HE
-
依托单位:
Cortical Signature and Modulation of Pain
-
批准号:10349650
-
项目类别:
-
资助金额:$57.36万
-
财政年份:2018
-
负责人:ZHIGANG HE
-
依托单位:
Cortical Signature and Modulation of Pain
-
批准号:10438580
-
项目类别:
-
资助金额:$79.54万
-
财政年份:2018
-
负责人:ZHIGANG HE
-
依托单位:
海外基金